Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 207.50 GBp
Change Today 0.00 / 0.00%
Volume 1.6K
LSIC On Other Exchanges
As of 11:35 AM 10/8/15 All times are local (Market data is delayed by at least 15 minutes).

lifeline scientific inc-new (LSIC) Snapshot

207.50 GBp
Previous Close
207.50 GBp
Day High
207.50 GBp
Day Low
207.50 GBp
52 Week High
09/22/15 - 252.50 GBp
52 Week Low
01/27/15 - 112.50 GBp
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

lifeline scientific inc-new (LSIC) Related Businessweek News

No Related Businessweek News Found

lifeline scientific inc-new (LSIC) Details

Lifeline Scientific, Inc., a medical technology company, develops products and services for cell, tissue, and organ transplantation and research in the United States and internationally. It offers LifePort Kidney Transporter, a medical device that provides enhanced kidney preservation, evaluation, and transport prior to transplantation. The company also provides single-use consumables and preservation solutions. In addition, it develops products for in vitro diagnostics and allograft tissues, such as heart valves, saphaneous veins, and cartilage and pancreatic islets for transplantation. The company was formerly known as Organ Recovery Systems, Inc. and changed its name to Lifeline Scientific, Inc. in December 2007. Lifeline Scientific, Inc. was founded in 1998 and is based in Itasca, Illinois.

Founded in 1998

lifeline scientific inc-new (LSIC) Top Compensated Officers

Founder, Chief Executive Officer and Executiv...
Total Annual Compensation: $629.9K
Compensation as of Fiscal Year 2014.

lifeline scientific inc-new (LSIC) Key Developments

Lifeline Scientific, Inc. Announces Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2015

Lifeline Scientific, Inc. announced unaudited consolidated earnings results for the six months ended June 30, 2015. For the period, the company's total net revenue was $15,019,466 compared with $15,117,975 a year ago. Income from operations was $134,847 compared with loss from operations of $8,214 a year ago. Income before income taxes was $98,108 compared with loss before income tax of $59,402 a year ago. Net income attributable to the company was $94,911 compared with net loss of $30,234 a year ago. Net cash provided by operating activities was $954,964 compared with net cash used in operating activities of $316,053 a year ago. Capital expenditures were $505,524 compared with $1,158,804 a year ago.

Lifeline Scientific Considers Range Of Options

The Board of Lifeline Scientific, Inc. (AIM:LSIC) plans to explore a range of options, which could include (though will not be limited to), a strategic merger, strategic acquisitions, a potential sale of Lifeline, and a potential listing of the Lifeline's shares on the NASDAQ market.

Lifeline Scientific, Inc. Announces Key Account Win in North America

Lifeline Scientific, Inc. announced a key account win in North America and further adoption in Europe and the Middle East, which combined are expected to contribute in excess of USD 1.2 million in annualised revenues. Lifeline has received a significant order for LifePort Kidney Transporters, related consumables and preservation solutions from the Birmingham, Alabama based regional transplant programme supporting the state of Alabama and portions of Georgia. This programme recovers up to 250 donor kidneys for transplant annually and it is expected that LifePort will be employed in most of these procedures. LifePort Kidney Transporter is the standard of care for machine preservation of donor kidneys in most donor organ procurement programmes within the US and in all provinces of Canada.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LSIC:LN 207.50 GBp 0.00

LSIC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for LSIC.
View Industry Companies

Industry Analysis


Industry Average

Valuation LSIC Industry Range
Price/Earnings 17.7x
Price/Sales 1.8x
Price/Book 2.7x
Price/Cash Flow 17.2x
TEV/Sales 1.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LIFELINE SCIENTIFIC INC-NEW, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at